Market Tracker

11/26 7:23am ET

Solazyme Inc (NASDAQ:SZYM)

2.62
Data as of Nov 25
 -0.02 / -0.76%
Today’s Change
2.59
Today|||52-Week Range
15.00
-75.94%
Year-to-Date

Today’s Trading

Previous close2.64
Today’s open2.63
Day’s range-- - --
Volume1,724,975
Average volume (3 months)1,899,135
Market cap$209.3M
Dividend yield--
Data as of 11/25/2014

Growth & Valuation

Earnings growth (last year)-32.12%
Earnings growth (this year)-15.33%
Earnings growth (next 5 years)+683.60%
Revenue growth (last year)-9.88%
P/E ratioNM
Price/Sales17.59
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
QUREUniqure NV+0.32+2.67%
PLXProtalix Biotherapeu...+0.03+1.45%
RTRXRetrophin Inc+0.31+3.58%
BPTHBio-Path Holdings In...0.000.00%
Data as of 11/25/2014

Financials

Next reporting dateFebruary 18, 2015
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$39.8M
Annual profit (last year)-$116.4M
Net profit margin-292.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jonathan S. Wolfson
Chief Operating &
Financial Officer
Tyler W. Painter
Corporate headquarters
San Francisco, California

Forecasts